FACTORS ASSOCIATED WITH INCONSISTENT DORNASE ALFA THERAPY IN PATIENTS WITH CYSTIC FIBROSIS

被引：0
|
作者：
Sawicki, G. S. [1 ]
VanDevanter, D. [2 ]
Schechter, M. S. [3 ]
Millar, S. [4 ]
Xu, Y. [5 ]
Pasta, D. [4 ]
Morgan, W. [6 ]
Konstan, M. [2 ]
机构：
[1] Childrens Hosp, Boston, MA 02115 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Emory Univ, Sch Med, Atlanta, GA USA
[4] ICON Late Phase & Outcomes Res, San Francisco, CA USA
[5] Genentech Inc, San Francisco, CA 94080 USA
[6] Univ Arizona, Tucson, AZ USA
来源：
PEDIATRIC PULMONOLOGY | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [41] Is Bronchoscopic Lung Lavage With Dornase Alfa A Therapeutic Option In Cystic Fibrosis?
    Nobuo, M. S. D. P. F.
    Pedrao, N. B.
    Athanazio, R. A.
    Rached, S. Z.
    Carvalho-Pinto, R. M.
    Cukier, A.
    Stelmach, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [42] Aerosolized dornase alfa in cystic fibrosis: Is there a role in the management of patients with early obstructive lung disease?
    Geller, DE
    PEDIATRIC PULMONOLOGY, 1997, 24 (02) : 155 - 158
  • [43] Clinical Use of Dornase Alfa Is Associated With a Slower Rate of FEV1 Decline in Cystic Fibrosis
    Konstan, Michael W.
    Wagener, Jeffrey S.
    Pasta, David J.
    Millar, Stefanie J.
    Jacobs, Joan R.
    Yegin, Ashley
    Morgan, Wayne J.
    PEDIATRIC PULMONOLOGY, 2011, 46 (06) : 545 - 553
  • [44] Dornase alpha and survival of patients with cystic fibrosis
    McIntyre, AM
    HOSPITAL MEDICINE, 1999, 60 (10): : 736 - 739
  • [45] Estimating effectiveness in an observational study: A case study of dornase alfa in cystic fibrosis
    Johnson, CA
    Butler, SM
    Konstan, MW
    Breen, TJ
    Morgan, WJ
    JOURNAL OF PEDIATRICS, 1999, 134 (06): : 734 - 739
  • [46] Targeting of dornase alpha therapy in adult cystic fibrosis
    Ledson, MJ
    Wahbi, Z
    Convery, RP
    Cowperthwaite, C
    Heaf, DP
    Walshaw, MJ
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1998, 91 (07) : 360 - 364
  • [47] DEVELOPMENT OF A LONG-ACTING VERSION OF DORNASE ALFA FOR THE TREATMENT OF CYSTIC FIBROSIS
    Guichard, M-J.
    Wilms, T.
    Ucakar, B.
    Leal, T.
    Vanbever, R.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (03) : A26 - A26
  • [48] Dornase alfa is well tolerated: Data from the Epidemiologic Registry of Cystic Fibrosis
    McKenzie, S. G.
    Chowdhury, S.
    Strandvik, B.
    Hodson, M. E.
    PEDIATRIC PULMONOLOGY, 2007, 42 (10) : 928 - 937
  • [49] What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates, AL
    JOURNAL OF PEDIATRICS, 2001, 139 (06): : 768 - 770
  • [50] Dornase alfa - A practical guide to patient selection and drug use in cystic fibrosis
    Shah, PL
    Hodson, ME
    BIODRUGS, 1997, 8 (06) : 439 - 445
12345